Pharmacokinetics of ceftizoxime in patients undergoing hemodialysis. 1982

P M Shah, and M Knobloch, and R Haag, and H F Kühnle

Serum pharmacokinetics of 1 g ceftizoxime were studied in eight patients undergoing chronic haemodialysis. Arterial blood samples were collected at 3, 60, 120, 180 and 240 minutes and before the next dialysis 2-3 days after injection of ceftizoxime. Three minutes after injection the serum levels were 122 +/- 8.4 microgram/ml and 19.4 +/- 1.7 microgram/ml at the end of the dialysis. Mean elimination half-life under haemodialysis was 2.1 hours. Serum concentrations ranged from 4.9 to 13 microgram/ml two to three days after the haemodialysis.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015296 Ceftizoxime A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders. Ceftizoxime Sodium,Cefizox,Ceftizoxime Monosodium Salt,FK-749,FK749,FR-13749,SK&F 88373-2,SKF-88373,FK 749,FR 13749,FR13749,Monosodium Salt, Ceftizoxime,SK&F 88373 2,SK&F 883732,SKF 88373,SKF88373,Salt, Ceftizoxime Monosodium,Sodium, Ceftizoxime

Related Publications

P M Shah, and M Knobloch, and R Haag, and H F Kühnle
August 1983, Antimicrobial agents and chemotherapy,
P M Shah, and M Knobloch, and R Haag, and H F Kühnle
September 1979, International journal of clinical pharmacology and biopharmacy,
P M Shah, and M Knobloch, and R Haag, and H F Kühnle
December 1991, The Japanese journal of antibiotics,
P M Shah, and M Knobloch, and R Haag, and H F Kühnle
August 1979, International journal of clinical pharmacology and biopharmacy,
P M Shah, and M Knobloch, and R Haag, and H F Kühnle
July 1991, Journal of clinical pharmacology,
P M Shah, and M Knobloch, and R Haag, and H F Kühnle
January 1983, Nephron,
P M Shah, and M Knobloch, and R Haag, and H F Kühnle
October 1986, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
P M Shah, and M Knobloch, and R Haag, and H F Kühnle
April 2017, Hemodialysis international. International Symposium on Home Hemodialysis,
P M Shah, and M Knobloch, and R Haag, and H F Kühnle
December 1991, Minerva medica,
P M Shah, and M Knobloch, and R Haag, and H F Kühnle
January 2004, European journal of drug metabolism and pharmacokinetics,
Copied contents to your clipboard!